Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters











Database
Language
Publication year range
1.
Curr Probl Cardiol ; 49(7): 102628, 2024 Jul.
Article in English | MEDLINE | ID: mdl-38729276

ABSTRACT

Mechanical prosthetic valve thrombosis (MPVT) is a common complication of valvular implantations. This study compared the efficacy and safety of different treatments for MPVT. A systematic search of electronic databases identified studies evaluating surgical, anticoagulant, and thrombolytic therapies. Although several studies of different types have been conducted to evaluate the efficacy of these treatment strategies the lack of randomized controlled trials has resulted in the inability to make a definitive conclusion about the pros and cons of these treatments. Recent treatments, such as slow and ultraslow infusion of thrombolytics, showed comparable efficacy and lower complication rates than traditional methods. Inadequate anticoagulant use is a major risk factor for MPVT, highlighting the importance of prevention. Treatment selection should be individualized based on patient factors and available expertise. Overall, slow and ultraslow infusion of thrombolytics may be a promising treatment option for MPVT.


Subject(s)
Anticoagulants , Fibrinolytic Agents , Heart Valve Prosthesis , Thrombolytic Therapy , Thrombosis , Humans , Heart Valve Prosthesis/adverse effects , Thrombosis/etiology , Thrombosis/prevention & control , Thrombolytic Therapy/methods , Thrombolytic Therapy/adverse effects , Fibrinolytic Agents/therapeutic use , Anticoagulants/therapeutic use , Risk Factors , Heart Valve Prosthesis Implantation/adverse effects , Heart Valve Prosthesis Implantation/methods , Treatment Outcome
SELECTION OF CITATIONS
SEARCH DETAIL